CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cordlife Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cordlife Group Ltd
1 Yishun Industrial Street 1
A'Posh Bizhub, # 06 01 09
Phone: +65 62380808p:+65 62380808 768160  Singapore Ticker: P8AP8A
Business Summary
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Company’s segments include Banking and Diagnostics. The banking segment comprises the collection, processing and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing and newborn metabolic screening. Its MOMS UP is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
8099 Health and allied services, not elsewhere classified
8071 Medical laboratories
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Acting Non-Independent Non-Executive Chairman of the Board Choon HouHo 51 2/29/2024 6/16/2011
Group Chief Executive Officer Pang FaiYiu 34 2/19/2024 2/19/2024
Group Chief Financial Officer Hnin YiThet 46 1/16/2023
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
StemLife Berhad B-7-15 KUALA LUMPUR Malaysia

Business Names
Business Name
Cordlife Stem Cell Technology Limited
CS Cell Technologies Pte. Ltd
Healthbaby Biotech (Hong Kong) Co. Limited
P.T. Cordlife Indonesia
P8A
StemLife Berhad

General Information
Number of Employees: 111 (As of 6/30/2011)
Outstanding Shares: 256,307,744 (As of 12/31/2023)
Shareholders: 1,782
Stock Exchange: SIN
Fax Number: +65 62381108


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024